Amneal Pharmaceuticals, Inc. (AMRX)
Makes and sells generic drugs, specialty medicines, and injectable pharmaceuticals worldwide.
$18.76+0.04%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+139.6%
The outlook
AMRX is trading near the top of its 52-week range with strong analyst backing—the consensus leans "Strong Buy" across four analysts. The stock is above both its 50- and 200-day moving averages, showing positive near-term momentum. The average analyst price target sits essentially in line with the current price, and the trailing P/E of 49.4 reflects a premium valuation.
What’s behind the score
Analyst consensusStrong Buy — 1.5 avg of 4 analysts
Price trendAbove its 50- & 200-day averages
52-week range100% of the way from its 52-week low to high
Price targetAvg target -0% vs current price
Analyst price target
~12-month · 4 analysts$18.75average target-0.1% vs now
Now $18.76
Low $16.00High $23.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$5.99B
52-wk high
$18.81
52-wk low
$7.67
50-day avg
$15.65
200-day avg
$13.35
Trailing P/E
49.4